These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31715179)
1. Cis/Trans Isomerization of Unsaturated Fatty Acids in Polysorbate 80 During Light Exposure of a Monoclonal Antibody-Containing Formulation. Prajapati I; Peters BH; Larson NR; Wei Y; Choudhary S; Kalonia C; Hudak S; Esfandiary R; Middaugh CR; Schöneich C J Pharm Sci; 2020 Jan; 109(1):603-613. PubMed ID: 31715179 [TBL] [Abstract][Full Text] [Related]
2. Near UV and Visible Light Photo-Degradation Mechanisms in Citrate Buffer: One-Electron Reduction of Peptide and Protein Disulfides promotes Oxidation and Cis/Trans Isomerization of Unsaturated Fatty Acids of Polysorbate 80. Prajapati I; Subelzu N; Zhang Y; Wu Y; Schöneich C J Pharm Sci; 2022 Apr; 111(4):991-1003. PubMed ID: 35108563 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody. Larson NR; Wei Y; Prajapati I; Chakraborty A; Peters B; Kalonia C; Hudak S; Choudhary S; Esfandiary R; Dhar P; Schöneich C; Middaugh CR J Pharm Sci; 2020 Jan; 109(1):633-639. PubMed ID: 31758949 [TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation. Doshi N; Giddings J; Luis L; Wu A; Ritchie K; Liu W; Chan W; Taing R; Chu J; Sreedhara A; Kannan A; Kei P; Shieh I; Graf T; Hu M Pharm Res; 2021 Mar; 38(3):531-548. PubMed ID: 33713012 [TBL] [Abstract][Full Text] [Related]
5. What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical Stress. Grabarek AD; Bozic U; Rousel J; Menzen T; Kranz W; Wuchner K; Jiskoot W; Hawe A J Pharm Sci; 2020 Jan; 109(1):871-880. PubMed ID: 31614127 [TBL] [Abstract][Full Text] [Related]
6. Geometrical isomerism of monounsaturated fatty acids: thiyl radical catalysis and influence of antioxidant vitamins. Chatgilialoglu C; Zambonin L; Altieri A; Ferreri C; Mulazzani QG; Landi L Free Radic Biol Med; 2002 Dec; 33(12):1681-92. PubMed ID: 12488136 [TBL] [Abstract][Full Text] [Related]
7. Development of a design of experiments optimized method for quantification of polysorbate 80 based on oleic acid using UHPLC-MS. Puschmann J; Evers DH; Müller-Goymann CC; Herbig ME J Chromatogr A; 2019 Aug; 1599():136-143. PubMed ID: 31003714 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability. Tomlinson A; Zarraga IE; Demeule B Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382 [TBL] [Abstract][Full Text] [Related]
9. Visible light triggers the formation of reactive oxygen species in monoclonal antibody formulations. Hipper E; Diederichs T; Kaiser W; Lehmann F; Buske J; Hinderberger D; Garidel P Int J Pharm; 2024 Aug; 661():124392. PubMed ID: 38942184 [TBL] [Abstract][Full Text] [Related]
10. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation. Gopalrathnam G; Sharma AN; Dodd SW; Huang L PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621 [TBL] [Abstract][Full Text] [Related]
11. Effect of polysorbate 80 quality on photostability of a monoclonal antibody. Singh SR; Zhang J; O'Dell C; Hsieh MC; Goldstein J; Liu J; Srivastava A AAPS PharmSciTech; 2012 Jun; 13(2):422-30. PubMed ID: 22362139 [TBL] [Abstract][Full Text] [Related]
12. Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations. Labrenz SR J Pharm Sci; 2014 Aug; 103(8):2268-77. PubMed ID: 24942482 [TBL] [Abstract][Full Text] [Related]
13. Development of UPLC-UV-ELSD Method for Fatty Acid Profiling in Polysorbate 80 and Confirmation of the Presence of Conjugated Fatty Acids by Mass Spectrometry, UV Absorbance and Proton Nuclear Magnetic Resonance Spectroscopy. Doyle M; Barnes A; Larson NR; Liu H; Yi L J Pharm Sci; 2023 Sep; 112(9):2393-2403. PubMed ID: 37295606 [TBL] [Abstract][Full Text] [Related]
14. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer. Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Polysorbate 80 by Liquid Chromatography-Mass Spectrometry to Understand Its Susceptibility to Degradation and Its Oxidative Degradation Pathway. Liu H; Jin Y; Menon R; Laskowich E; Bareford L; de Vilmorin P; Kolwyck D; Yeung B; Yi L J Pharm Sci; 2022 Feb; 111(2):323-334. PubMed ID: 34416271 [TBL] [Abstract][Full Text] [Related]
16. Cis-trans isomerization of polyunsaturated fatty acid residues in phospholipids catalyzed by thiyl radicals. Ferreri C; Costantino C; Perrotta L; Landi L; Mulazzani QG; Chatgilialoglu C J Am Chem Soc; 2001 May; 123(19):4459-68. PubMed ID: 11457231 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations. Bensaid F; Dagallier C; Authelin JR; Audat H; Filipe V; Narradon C; Guibal P; Clavier S; Wils P Int J Pharm; 2022 Mar; 615():121496. PubMed ID: 35074436 [TBL] [Abstract][Full Text] [Related]
18. Fatty Acids Can Induce the Formation of Proteinaceous Particles in Monoclonal Antibody Formulations. Zhang J; He J; Smith KJ J Pharm Sci; 2022 Mar; 111(3):655-662. PubMed ID: 34666046 [TBL] [Abstract][Full Text] [Related]
19. A Mechanistic Understanding of Polysorbate 80 Oxidation in Histidine and Citrate Buffer Systems-Part 2. Doyle Drbohlav LM; Sharma AN; Gopalrathnam G; Huang L; Bradley S PDA J Pharm Sci Technol; 2019; 73(4):320-330. PubMed ID: 30770486 [TBL] [Abstract][Full Text] [Related]
20. A Newly Identified Impurity in Polysorbate 80, the Long-Chain Ketone 12-Tricosanone, Forms Visible Particles in a Biopharmaceutical Drug Product. Hampl V; Guo X; Ehrenstrasser C; Viertler M; Rayner L; Campanelli G; Schipflinger R; Thewes K; Cerreti A; Boehm S; Sonderegger C J Pharm Sci; 2018 Jun; 107(6):1552-1561. PubMed ID: 29499279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]